INC nabs ex-Pfizer VP to oversee development; InVentiv invests in clinical trial app developer;

> InVentiv Health has bought an equity stake in virtual clinical trials outfit Mytrus, planning to commercialize its mobile apps. Article

> INC Research has appointed ex-Pfizer ($PFE) vice president James Taylor to run their clinical development operation. More

> Scottish CMO Angel Biotechnology has run into financial trouble, and the company is selling off its assets, unloading its collagen manufacturing unit to Collbio. Report

> Datatrak, an eClinical service provider, increased its revenue by 23% to $9.7 million in 2012. Results

> CMO Lonza has settled its patent lawsuit with Germany's Hyglos, giving the latter company the right to use Lonza's technology to produce endotoxin products. Item

> The FDA wants to spend $10 million to increase its oversight capabilities in China. Story

Suggested Articles

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.

After three full business days in the position, an abrupt about-face has LabCorp Diagnostics’ CEO John Ratliff heading for the exit.

The initiative will see Evotec mine a kidney biobank for new renal therapy targets before the joint venture out-licenses resulting assets to Vifor.